2018年美国安全网性传播疾病临床服务的可及性
2018年调查美国地方卫生部门,评估安全网性传播疾病临床服务可及性。326个地方卫生部门完成调查(应答率49%),64.4%报告辖区内有诊所提供安全网性传播疾病服务,性传播疾病诊所是40.5%辖区的主要提供者。特定服务可及性差异大,不到四分之一诊所提供梅毒快速血浆反应素试验或暗视野显微镜检查。
要点
- 64.4%受访地方卫生部门报告辖区内有诊所提供安全网性传播疾病服务,性传播疾病诊所为40.5%辖区的主要提供者。
- 与其他诊所相比,性传播疾病诊所更常提供当日服务、乙型肝炎疫苗接种、梅毒快速血浆反应素试验、淋病即时检验、滴虫即时检验及生殖器外衣原体或淋病检测。
- 不到四分之一诊所提供梅毒快速血浆反应素试验或暗视野显微镜检查。
核心结论
- 三分之一的地方卫生部门报告没有安全网性传播疾病服务或不知道这些服务,特定服务的可及性各不相同。
- 在没有资源扩展的情况下,地方卫生部门可能探索与医疗系统合作及检测创新来扩大性传播疾病服务。
研究设计与样本
- 2018年对美国地方卫生部门进行调查,评估安全网提供者及特定性传播疾病临床服务(包括即时检验和治疗)的可及性。
- 共有326个地方卫生部门完成调查(应答率49%)。
- 2019年使用Rao-Scott卡方检验按诊所类型(性传播疾病诊所与其他诊所)比较服务可及性。
主要发现
- 64.4%的受访者报告其辖区内有诊所提供安全网性传播疾病服务。
- 有提供性传播疾病服务的安全网诊所这一情况在中等和大型辖区更常见。
- 性传播疾病诊所在40.5%的辖区是主要提供者。
- 大多数诊所提供人乳头瘤病毒疫苗接种以及淋病和梅毒的适当即时治疗。
- 不到四分之一的诊所提供即时快速血浆反应素试验或暗视野显微镜梅毒检测。
临床怎么用
- 原文未据此给出推荐。
- 作者认为,在没有资源扩展的情况下,地方卫生部门可能探索与医疗系统合作及检测创新来扩大性传播疾病服务。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Safety-net sexually transmitted disease services can prevent transmission of sexually transmitted disease. This study assesses the availability of safety-net sexually transmitted disease clinical services across the U.S. METHODS: A 2018 survey of U.S. local health departments examined the availability of safety-net providers and the availability of specific sexually transmitted disease clinical services, including point-of-care testing and treatment. In 2019, Rao-Scott chi-square tests were used to compare service availability by clinic type (sexually transmitted disease clinic versus other clinics). RESULTS: A total of 326 local health departments completed the survey (49% response rate). Of respondents, 64.4% reported that a clinic in their jurisdiction provided safety-net sexually transmitted disease services. Having a safety-net clinic that provided sexually transmitted disease services was more common in medium and large jurisdictions. Sexually transmitted disease clinics were the primary provider in 40.5% of jurisdictions. A wide range of specific sexually transmitted disease services was offered at the primary safety-net clinic for sexually transmitted diseases. Most clinics offered human papillomavirus vaccination and appropriate point-of-care treatment for gonorrhea and syphilis. Fewer than one-quarter of clinics offered point-of-care rapid plasma reagin or darkfield microscopy syphilis testing. Compared with other clinics, services more commonly offered at sexually transmitted disease clinics included same-day services, hepatitis B vaccination, rapid plasma reagin testing (syphilis), any point-of-care testing for gonorrhea, point-of-care trichomonas testing, and extragenital chlamydia or gonorrhea testing. CONCLUSIONS: One-third of local health departments reported no safety-net sexually transmitted disease services or were not aware of the services, and availability of specific services varied. Without an expansion of resources, local health departments might explore collaborations with healthcare systems and innovations in testing to expand sexually transmitted disease services.
引用
- Leichliter JS, O'Donnell K, Kelley K, et al. Availability of Safety-net Sexually Transmitted Disease Clinical Services in the U.S., 2018. Am J Prev Med. 2020. PMID: 32001050. doi:10.1016/j.amepre.2019.11.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。